Please wait a minute...
文章检索
预防医学  2022, Vol. 34 Issue (7): 727-731    DOI: 10.19485/j.cnki.issn2096-5087.2022.07.016
  疾病监测 本期目录 | 过刊浏览 | 高级检索 |
永嘉县结直肠癌筛查结果分析
郑沛, 卢丽微, 朱福乾, 戴曙杰
永嘉县疾病预防控制中心慢病科,浙江 永嘉 325100
Pevalence of colorectal cancer in Yongjia County
ZHENG Pei, LU Liwei, ZHU Fugan, DAI Shujie
Department of Chronic Diseases, Yongjia Center for Disease Control and Prevention, Yongjia, Zhejiang 325100, China
全文: PDF(803 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解2020—2021年浙江省永嘉县结直肠癌患病情况,为结直肠癌防治提供依据。方法 选择50~74岁永嘉县户籍居民为筛查对象,采用《浙江省重点人群结直肠癌筛查风险评估问卷》和粪便潜血试验筛查阳性人群,问卷阳性或粪便潜血阳性为筛查阳性。筛查阳性人群行结直肠镜检查,分析问卷阳性、粪便潜血阳性和筛查阳性的高危病变(结直肠癌和癌前病变)检出情况。结果 调查102 504人,完成问卷调查和粪便潜血检测46 138人,占45.01%。筛查阳性9 733人,筛查阳性率为21.10%;其中问卷阳性3 291人,问卷阳性率为7.13%;粪便潜血阳性6 993人,粪便潜血阳性率为15.16%。男性筛查阳性率为27.06%,高于女性的17.14%(χ2=654.747,P<0.001);不同年龄居民筛查阳性率差异有统计学意义(χ2=418.264,P<0.001),其中65~<70岁(26.43%)和70~74岁(24.98%)居民较高。结直肠镜检查2 966人,依从率为30.47%;检出高危病变348例,包括癌前病变317例和结直肠癌31例,高危病变检出率为11.73%,结直肠癌检出率为1.05%。筛查阳性的男性高危病变检出率高于女性(15.77%和7.59%;χ2=47.915,P<0.001);不同年龄筛查阳性居民的高危病变检出率差异有统计学意义(χ2=25.909,P<0.001),其中65~<70岁(14.32%)和70~<74岁(15.49%)居民较高。结论 永嘉县50~74岁居民结直肠癌高危病变检出率为11.73%,其中男性、65岁及以上老年人为高危人群;应进一步普及结直肠癌防治知识,提高结直肠癌筛查依从性。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
郑沛
卢丽微
朱福乾
戴曙杰
关键词 结直肠癌筛查依从性    
AbstractObjective To investigate the prevalence of colorectal cancer in Yongjia County, Zhejiang Province from 2020 to 2021, so as to provide insights into colorectal cancer control. Methods Residents registered in Yongjia County at ages of 50 to 74 years were sampled, and positive populations were screened using Zhejiang Provincial Questionnaires for Assessment of Risk of Colorectal Cancer Screening among High-risk Populations and fecal occult blood test, and those positive for questionnaires or fecal occult blood test served as a positive screening. Residents with a positive screening underwent colonoscopy, and the detection of high-risk lesions (colorectal cancer and pericancer lesions) was analyzed among those positive for questionnaires, fecal occult blood test and screening. Results Totally 102 504 residents were tested, and 46 138 (45.01%) residents completed questionnaire surveys and fecal occult blood tests. The rate of positive screening was 21.10%, and the rate of positive questionnaire surveys was 7.13%, while the positive rate of fecal occult blood test was 15.16%. The rate of positive screening was significantly higher in men than in women (27.06% vs. 17.14%; (χ2=654.747, P<0.001), and there was an age-specific proportion of positive screening (χ2=418.264, P<0.001), with high prevalence seen in residents at ages of 65 to 69 years (26.43%) and 70 to 74 years (24.98%). Colonoscopy was performed among 2 966 residents, with a compliance rate of 30.47%, and colonoscopy detected 348 residents with high-risk lesions, including 317 cases with pericancer lesions and 31 cases with colorectal cancer, with 11.73% detection of high-risk lesions and 1.05% detection of colorectal cancer. The prevalence of high-risk lesions was significantly higher in men with positive screening than in women with positive screening (15.77% vs. 7.59%; χ2=47.915, P<0.001), and there was a significant difference in the detection of high-risk lesions among residents with positive screening at different age groups (χ2=25.909, P<0.001), with a high detection in residents at ages of 65 to 69 years (14.32%) and 70 to 74 years (15.49%). Conclusions The prevalence of high-risk lesions of colorectal cancer is 11.73% among residents living in Yongjia County at ages of 50 to 74 years, and men and the elderly at ages of 65 years and older are high-risk populations for colorectal cancer. Improving the awareness of colorectal cancer prevention knowledge and the compliance of colorectal cancer screening is recommended.
Key wordscolorectal cancer    screening    compliance
收稿日期: 2022-03-11      修回日期: 2022-04-08      出版日期: 2022-07-10
中图分类号:  R195.4  
作者简介: 郑沛,本科,主治医师,主要从事慢性病与地方病防治工作
通信作者: 郑沛,E-mail:379282146@qq.com   
引用本文:   
郑沛, 卢丽微, 朱福乾, 戴曙杰. 永嘉县结直肠癌筛查结果分析[J]. 预防医学, 2022, 34(7): 727-731.
ZHENG Pei, LU Liwei, ZHU Fugan, DAI Shujie. Pevalence of colorectal cancer in Yongjia County. Preventive Medicine, 2022, 34(7): 727-731.
链接本文:  
https://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2022.07.016      或      https://www.zjyfyxzz.com/CN/Y2022/V34/I7/727
[1] 吴春晓,顾凯,龚杨明,等.2015年中国结直肠癌发病和死亡情况分析[J].中国癌症杂志,2020,30(4):241-245.
WU C X,GU K,GONG Y M,et al.Analysis of incidence and mortality of colorectal cancer in China,2015[J].China Oncol,2020,30(4):241-245.
[2] 刘宗超,李哲轩,张阳,等.2020全球癌症统计报告解读[J].肿瘤综合治疗电子杂志,2021,7(2):1-13.
LIU Z C,LI Z X,ZHANG Y,et al.Interpretation on the report of global cancer statistics 2020[J].J Multidiscipl Cancer Manag(Electron Version),2021,7(2):1-13.
[3] 朱陈,龚巍巍,钟节鸣,等.浙江省重点人群结直肠癌筛查项目设计和实施方案[J].中国肿瘤,2020,29(12):899-903.
ZHU C,GONG W W,ZHONG J M,et al.Zhejiang colorectal cancer screening program:overview and study design[J].China Cancer,2020,29(12):899-903.
[4] 国家癌症中心中国结直肠癌筛查与早诊早治指南制定专家组.中国结直肠癌筛查与早诊早治指南(2020,北京)[J].中华肿瘤杂志,2021,43(1):16-38.
National Cancer Center,Expert Group of the Development of China Guideline for the Screening,Early Detection and Early Treatment of Colorectal Cancer.China guideline for screening,early detection and early treatment of colorectal cancer(2020,Beijing)[J].Cnina J Oncol,2021,43(1):16-38.
[5] 柏愚,杨帆,马丹,等.中国早期结直肠癌筛查及内镜诊治指南(2014年,北京)[J].胃肠病学,2015,20(6):345-365.
BAI Y,YANG F,MA D,et al.Guidelines for early screening and endoscopic diagnosis and treatment of colorectal cancer in China(Beijing,2014)[J].Chin J Gastroenterol,2015,20(6):345-365.
[6] 马铭骏,李延青.探索中国结直肠癌筛查新模式[J].中国医刊,2021,56(12):1281-1284.
MA M J,LI Y Q.Explore new models of colorectal cancer screening in China[J].Chin J Med,2021,56(12):1281-1284.
[7] 王露尧,张鹭鹭.中国结直肠癌发病和死亡情况及防控策略[J].解放军医院管理杂志,2021,28(12):1195-1197.
WANG L Y,ZHANG L L.Incidence and mortality of colorectal cancer and prevention-control strategies in China[J].Hosp Adm J Chin PLA,2021,28(12):1195-1197.
[8] 宋洁,王静,张晓岚.《2021年美国胃肠病学会结直肠癌筛查指南》解读[J].临床荟萃,2021,36(9):828-831.
SONG J,WANG J,ZHANG X L.The guidelines for colorectal cancer screening by the American College of Gastroenterology in 2021-an interpretation[J].Clin Focus,2021,36(9):828-831.
[9] 王颖,潘峰,陈泽琨,等.北京市大兴区农村地区结直肠癌筛查结果及不同筛检工具比较[J].中国公共卫生,2020,36(1):41-46.
WANG Y,PAN F,CHEN Z K,et al.Colorectal cancer screening with questionnaire survey and fecal occult blood test among rural adults in Daxing district of Beijing:a comparison analysis[J].Chin J Public Health,2020,36(1):41-46.
[10] 覃勇军. 结直肠癌的发病因素及高危人群的预防对策[J].吉林医学,2021,42(6):1350-1352.
QIN Y J.The risk factors of colorectal cancer and the prevention strategies of high risk population[J].Jilin Med J,2021,42(6):1350-1352.
[11] 顾芳慧,杨雷,张希,等.北京市结直肠癌高危人群内镜筛查依从性分析及对策探讨[J].中国预防医学杂志,2021,22(6):428-433. GU F H,YANG L,ZHANG X,et al.Analysis on the compliance with endoscopic screening for colorectal cancer among high-risk population in Beijing[J].Chin Prev Med,2021,22(6):428-433.
[12] 师金,梁迪,李道娟,等.中国城市癌症早诊早治项目筛查依从性及影响因素研究[J].中国肿瘤,2021,30(8):591-599.
SHI J,LIANG D,LI D J,et al.Research on the screening compliance and influencing factors of cancer screening program in urban China[J].China Cancer,2021,30(8):591-599.
[13] 郑亦青. 老年人大肠癌筛查的动态分析及依从性研究[D].上海:上海交通大学,2016.
ZHENG Y Q.Dynamic observation and analysis on colorectal cancer screening in the elderly[D].Shanghai:Shanghai Jiao Tong University,2016.
[14] 杨金华,沈飞琼,薛峰,等.2007—2016年浙江省嘉善县结直肠癌筛查方案应用评价[J].中国肿瘤,2020,29(12):919-924.
YANG J H,SHEN F Q,XUE F,et al.Evaluation of colorectal cancer screening program in Jiashan County of Zhejiang Province,2007-2016[J].China Cancer,2020,29(12):919-924.
[15] 陈奇峰,陈康康,李金,等.2011—2019年绍兴市结直肠癌发病趋势分析[J].预防医学,2021,33(11):1146-1148.
CHEN Q F,CHEN K K,LI J,et al.Incidence trend of colorectal cancer in Shaoxing from 2011 to 2019[J].Prev Med,2021,33(11):1146-1148.
[1] 周凡, 王小红, 陈梦倩, 张小兰, 徐则林. 2016—2027年金华市结直肠癌发病和死亡趋势分析及预测[J]. 预防医学, 2026, 38(1): 26-30.
[2] 李玉荣, 王冬飞, 高媛媛, 蒋园园, 林君英, 肖段段. 2010—2024年萧山区结直肠癌发病趋势分析[J]. 预防医学, 2025, 37(9): 927-931,936.
[3] 王剑铃, 沈小华, 李婷, 宋维红. 疗休养老年人老年综合评估结果分析[J]. 预防医学, 2025, 37(6): 593-597.
[4] 王晓闪, 叶丽香, 陈莉, 李敏香, 王心语, 蔡小霞. 基于潜在剖面分析的慢性病住院患者服药依从性影响因素分析[J]. 预防医学, 2025, 37(3): 217-222.
[5] 李佳文, 熊小梅, 王育珊. 身体测量指标筛查代谢综合征的效果比较[J]. 预防医学, 2025, 37(2): 163-167,172.
[6] 张莹, 陈伊绚, 高玥, 王晔, 李剑森, 韩毓桐, 魏文强, 廖羽. 2020年广东省肿瘤登记地区结直肠癌流行特征分析[J]. 预防医学, 2025, 37(10): 997-1001.
[7] 陈铭睿, 林玲, 楚楚, 黄捷, 韩亚蓉, 蔡波, 韩颖颖. 2013—2022年南通市结直肠癌发病和死亡趋势分析[J]. 预防医学, 2025, 37(10): 1039-1044.
[8] 刘宇丹, 张彩云, 郭明媚, 郑宇娟, 贾铭, 杨佳乐, 侯嘉宁, 赵华. 慢性病共病患者服药依从性影响因素的Meta分析[J]. 预防医学, 2024, 36(9): 790-795,800.
[9] 梁薇, 任梦婷, 张文科, 杨琳, 王红雨. 滁州市中小学生脊柱侧弯筛查结果[J]. 预防医学, 2024, 36(7): 607-610.
[10] 蒋鸣孝, 李剑, 黄旭云. 上城区结直肠癌筛查结果分析[J]. 预防医学, 2024, 36(6): 501-505.
[11] 葛晓蕾, 张伟波, 陈春梅, 朱有为, 刘彦丽, 谢斌, 蔡军, 朱益. 长效抗精神病药物治疗的精神分裂症病例分析[J]. 预防医学, 2024, 36(5): 412-415.
[12] 和金金, 朱陈, 潘婷婷, 黄文雯, 蒋秉洁, 余炜燕, 王乐, 吴维妙, 杭栋, 杜灵彬. 定性和定量粪便免疫化学试验筛查结直肠癌效果评价[J]. 预防医学, 2024, 36(4): 317-321.
[13] 胡军路, 冯慧慧, 陈文迪. 献血前健康筛查软件介绍及应用[J]. 预防医学, 2024, 36(4): 362-364.
[14] 陈淑淑, 龚巍巍, 关云琦, 周晓燕, 潘劲, 戴品远, 王浩, 李娜, 俞敏. 1990—2019年浙江省结直肠癌疾病负担和危险因素分析[J]. 预防医学, 2024, 36(3): 203-206.
[15] 高菡璐, 俞晓芳, 吕乐彬, 叶国良, 樊金卿. 多靶点粪便DNA、肠道菌群、癌胚抗原及水果摄入对结直肠癌风险的交互作用研究[J]. 预防医学, 2024, 36(3): 219-223.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed